EMA Prepares To Deliver Verdict On Bevacizumab In Wet AMD

Opinion Could Be Drug's First OK For Ocular Use

 
• By Ian Schofield

This week could finally see an ophthalmic version of the anticancer drug bevacizumab recommended for use in wet AMD across the EU. Several other new products are also up for a CHMP opinion.

Subcutaneous injection
Bevacizumab is often used off label as an intraocular injection for AMD • Source: Shutterstock

More from Europe

More from Geography